Aicardi syndrome

Last revised by Frank Gaillard on 9 Feb 2025

Aicardi syndrome is a rare severe developmental disorder. It results from an X-linked genetic defect that is fatal in males and, therefore, only manifests in females (except for rare 47, XXY cases).

Aicardi syndrome is distinct from Aicardi-Goutieres syndrome, although both are named after Jean Aicardi (see below). 

Due to its rarity, epidemiological data is limited. However, its incidence has been postulated at ~1/100000, with a prevalence of over 850 cases in the US and 4,000 globally. No ethnicity bias has been found 5.

Aicardi syndrome is diagnosed clinically, supported by neuroimaging and EEG findings and sometimes genetic studies. The classic triad must be present 6:

  1. agenesis of the corpus callosum

  2. chorioretinal lacunae

  3. infantile spasms or early-onset epilepsy

Neuroimaging features (see below) and EEG findings are supportive. In some cases speficic mutation may be identified, however, there is no single confirmatory test, and most cases arise from de novo mutations.

The typical presentation in infancy is with a triad of:

Although in some instances mutations in specific genes on the X chromosome have been identified (e.g. TEAD1 and OCEL1) these are heterogeneous 7.

Characteristic malformations affect the brain, spine and eyes and include:

First described in 1961 by Jean Francois Marie Aicardi (1926-2015), a French neuropaediatrician 2.

Cases and figures

  • Case 1: showing agenesis of corpus callosum
  • Case 1: showing grey matter heterotopia
  • Case 2
  • Case 3
  • Case 4
:

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.